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RESUMEN
Aceite de oliva y cáncer.
Numerosos estudios en los últimos años han determinado la
existencia de una asociación entre las grasas procedentes de la
dieta y el cáncer. Los ácidos grasos poliinsaturados (PUFA) de la
familia n-6 pueden tener efectos proliferativos y angiogénicos, lo
cual se debe en parte a que son especialmente sensibles a la pe-
roxidación lipídica, formándose aldehídos que reaccionan con las
bases del ADN y por lo tanto aductos exocíclicos con propiedades
genotóxicas. Por el contrario, el consumo de dietas ricas en áci-
dos grasos monoinsaturados (MUFA) está relacionado con un
menor riesgo de distintos tipos de cáncer. Si bien, los datos epide-
miológicos no siempre concuerdan con los datos experimentales.
Los componentes menores del aceite de oliva (extra virgen), fun-
damentalmente el hidroxitirosol y tocoferol, son antioxidantes y
secuestradores de radicales libres. Pueden minimizar la cantidad
de especies reactivas de oxígeno que se generan por la peroxida-
ción lipídica y además los MUFA son menos sensibles a la oxida-
ción, por lo que se reduce el daño del ADN.
PALABRAS-CLAVE: Aceite de oliva; Ácidos grasos monoin-
saturados; Componentes menores; Antioxidantes; Fenólicos;
Dieta Mediterránea
SUMMARY
Olive oil and cancer.
In the last years, numerous studies have examined the
association of dietary fat and cancer. Polyunsaturated fatty acids
(PUFA) from n-6 family display a strong promoting effect, this may
be partially due to the especially prone to lipid peroxidation of
PUFA that leads to formation of aldehydes, which react with DNA
bases, forming genotoxic exocyclic etheno(epsilon)-adducts. On
the contrary, there are growing evidences that monounsaturated
oils, like olive oil, may be associated with a decreased risk of
some cancers. However, the epidemiological data do not fully
agree with the experimental ones previously published. Minor
compounds from (extra virgin) olive oil, mainly phenolics like
hydroxytyrosol and tocopherol, are antioxidants and radical
scavenging. They can minimize the amount of reactive oxygen
species (ROS) generated by fatty acid peroxidation and in the
case of monounsaturated fatty acids (MUFA) the DNA damage
can be reduced by a lower lipid peroxidation.
KEY-WORDS: Olive oil; Monounsaturated fatty acids;
Minor compounds; Antioxidants; Phenolics; Mediterranean
diet.
1. INTRODUCTION
Cancer develops when cells in a part of the body
begin to grow out of control. Although there are many
kinds of cancer, they all start because of
out-of-control growth of abnormal cells. Normal body
cells grow, divide, and die in an orderly fashion. If
DNA damage occurs, it is repaired in most of the
cases. Un-repaired DNA alterations can be fixed as
mutations in proliferating cells only and mutations of
very few strategic genes can induce tumour formation,
the most relevant are those activating proto-oncogenes
and inactivating tumour suppressor genes. A series of
mutations and/or epigenetic changes is required to
drive transformation of a normal cell into malignant
tumour. The apparently unrestricted growth has to be
accompanied by a mechanism preserving telomeres
which otherwise shorten with succeeding cell divisions
leading to growth arrest. The majority of cancers in
humans are induced by carcinogenic factors present
in our environment including our food.
Cancer usually forms as a tumour. Malignant
tumours show a greater degree of anaplasia and
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have the properties of invasion and metastasis.
Some cancers, like leukaemia, do not form tumours.
Instead, these cancer cells involve the blood and
blood-forming organs and circulate through other
tissues where they grow. To invade the surrounding
tissues epithelial tumour cells have to lose some
adhesion molecules keeping them attached to each
other and to produce enzymes able to dissolve the
elements of the basement membrane. Benign
(non-cancerous) tumours do not spread to other
parts of the body and, with very rare exceptions, are
not life threatening.
During the multistage process of carcinogenesis,
only rarely selected cells could proceed through a
series of molecular changes from one stage to the
next one along the pathway leading them ultimately
to the formation of malignant tumour. At each stage,
the pathway leading to malignancy is only one of the
possible routes and different natural anticancer
defence mechanisms further diminishing cancer risk.
The peculiarity of these defence mechanisms stems
from the fact that actually the most effective of them
seem to operate at the very early stage proceeding
the formation of the neoplastic cell. The examples
given below could illustrate the issue (Jakobisiak et
al., 2003):
· Many chemical carcinogens as well as ionizing
and ultraviolet radiation are carcinogenic
mainly through the induction of reactive oxygen
species (ROS) able to produce DNA damage.
However, various natural substances, many of
which are termed antioxidants, present in our
food or synthesized in our organism inhibit the
formation of, trap or decompose ROS
preventing their carcinogenic activity.
· Toxic compounds, including carcinogens,
entering our cells are detoxified by enzymes
and/or are removed from target epithelial
tissues by a group of membrane proteins.
· If the above-mentioned mechanisms do not
prevent carcinogens from gaining access to
genes, damage of DNA could occur.
· Damage of DNA is probably repaired in most of
the cases.
· Even if unrepaired, DNA damage can produce
mutations and neoplastic transformation of
only a small number of cells, usually stem
cells, because the remaining cells are
differentiated, do not proliferate and are
committed to death.
· Only mutations of very few critical genes can
induce tumour formation, the most relevant are
those activating proto-oncogenes and
inactivating tumour suppressor genes.
· Not a single mutation but a series of mutations
and epigenetic changes is required to drive
transformation of a normal cell into a malignant
one and into the tumour. It is estimated that
four to six genetic changes are required for the
formation of a malignant tumour in humans.
· Even if a given cell achieved an apparently
unrestrained growth due to activation of
appropriate proto-oncogenes and inactivation
of some tumour suppressor genes, telomeres
shorten progressively with succeeding cell
divisions leading to growth arrest unless
telomerase is activated.
· Tumour cannot develop beyond the size of
1--2 mm in diameter without the induction of
angiogenesis.
· Invasion and dissemination of tumour cells is
prevented by some natural mechanisms. As for
epithelial cells, adhesion molecules keep them
bound to each other and they usually lack the
enzymes able to dissolve the basement
membranes.
· Tumour cells invading the surrounding tissues
and penetrating lymphatic and blood vessels to
disseminate and to form metastases can be
recognized and eliminated by the immune
system.
2. MEDITERRANEAN DIET AND CANCER
The incidence of cancer overall in Mediterranean
countries is lower than in Scandinavian countries
and the United States. This is mostly accounted for
by the lower incidence among Mediterranean
countries of cancer of the large bowel, breast,
endometrial, and prostate. These forms of cancer
have been linked to dietary factors, particularly low
consumption of vegetables and fruit, and to a certain
extent, high consumption of meat. The traditional
Mediterranean diet is characterized by high
consumption of foods of plant origin, relatively low
consumption of red meat, and high consumption of
olive oil, which in several studies has been reported
to be more beneficial against cancer than other
forms of added lipids.
Cancer has been one of the main diseases of the
last century, and nowadays many of them do not
have solution yet. Some scientists say that this
disease is a result of a degeneration of the own body
when it is exposed to potential tumorigenic
substances (environmental factors) defined broadly
to include tobacco, pollution, alcohol or diet. Among
these factors, unhealthy diet is more likely to affect
personal cancer risk. Research shows that about
one-third of all cancer deaths are related to dietary
factors and lack of physical activity in adulthood.
In the last years, numerous studies have
examined the association of dietary fat and cancer.
For some cancer, mainly breast cancer, the results of
these prospective studies have provided little
support for an important influence of dietary fat
intake (Willet, 2001). The role of dietary fat in other
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cancers is not as cleary defined, although it appears
that associations of fat intake with colorectal cancer
is specific to fat from animal sources or may be
attributed to meat intake, rather than fat per se
(Potter, 1996).
In models of breast and colon cancer, saturated
fats such as beef fat or lard, display only a weak
promoting effect, with the incidence of induced tumours
being similar at intake levels of 40% and 10% of energy
(Weisburger, 1997). On the other hand, n-6-PUFA rich
oils display a strong promoting effect and this may be
due to the especially prone to lipid peroxidation initiated
and propagated by reactive oxygen species (ROS),
leading to the formation of highly mutagenic exocyclic
DNA adducts (Weisburger, 1997; Hong et al., 2000;
Owen et al., 2000a).
Interestingly, there is increased evidence that
monounsaturated oils are associated with a lower
risk of some cancers, which agrees with the
composition of (extra virgin) olive oil and the potential
role of monounsaturated fatty acids (MUFA) and
minor compounds protective against ROS.
3. THE ROLE OF FATTY ACIDS FROM OLIVE
   OIL IN CANCER
A review, by Lipworth et al. (2000), summarizes
the association of olive oil intake with cancer risk in
humans. The authors concluded that olive oil does
not have the cancer-promoting potential of other fat
types. However, additional studies will be required to
confirm this hypothesis.
3.1. Olive oil and breast cancer
3.1.1. Experimental data
There are many reports in the last 30 years
showing the effect of olive oil and other oils in
animals. It is well known that is necessary a minimal
intake of essential fatty acids in the form of linoleic
acid (18:2n-6) to assess the maximal tumorigenic
response of saturated fatty acids (SFA) (Ip et al.,
1985). Nevertheless, cancer promotion not only
depends on the amount of fats, but also on the fatty
acid composition of the fat (Cohen et al., 1986a).
Other experiments comparing different oils from
corn, safflower, coconut and olive indicated that olive
oil is the lesser inducer of mammary tumours (Cohen
et al., 1986b; Cohen, 1987).
One of the mechanisms to explain how MUFA
(olive oil) and medium-chain SFA does not promote
mammary tumorigenesis is recurrent and mainly
related to the competitive interactions between these
fatty acids and the arachidonic acid (20:4n-6) for the
enzymes of the eicosanoid biosynthetic pathway.
Another one is that MUFA are less prone to lipid
peroxidation that requires two or more unsaturated
bonds in the fatty acid molecule (Mataix e  al., 1993;
Owen et al., 2000a). Therefore, the level of ROS is
lower when dietary PUFA are replaced by MUFA and
in turn, there is a decrease in the level of exocyclic
DNA adducts.
3.1.2. Epidemiological data
It has been described that at least in Greece and
Spain long-time consumption of olive oil is
associated with decreased risk of breast cancer
(Martin-Moreno et al., 1994; Trichopoulou et al.,
1995), which is not true for n-6 PUFA (Hunter et al.,
1996; Willet, 1997; Holmes, 1999). However, there
are also contradictory epidemiological studies
showing no beneficial effects derived from olive oil
intake (Yu et al., 1990; Gaard et al., 1995; Yuan et al.,
1995).
Recently, Sieri et al. (2004) evaluated the
association between dietary patterns and risk of
developing breast cancer in an Italian cohort
(ORDET cohort). Women volunteers were recruited
from 1987 to 1992 from residents in Varese province,
northern Italy. Participants completed a
semiquantitative food frequency questionnaire.
Using nutritional data from 8984 women with an
average follow up of 9.5 years and 207 incident
cases of breast cancer. The authors found four
dietary patterns, which explained 30% of the
variance: salad vegetables (mainly consisting of raw
vegetables and olive oil); western (mainly consisting
of potatoes, red meat, eggs and butter); canteen
(pasta and tomato sauce); and prudent (cooked
vegetables, pulses, and fish, with negative loading
on wines and spirits). After adjustment for potential
confounders, only the salad vegetables pattern
containing olive oil was associated with significantly
lower (34-35%) breast cancer incidence (RR = 0.66,
CI (95%) = 0.47-0.95 comparing highest with lowest
tertile) with a significant linear trend (P = 0.016).
Women with body mass index <25 had an even
greater risk reduction in the highest tertile of the
salad vegetables pattern (>50% less risk than the
lowest tertile, RR = 0.39, CI (95%) = 0.22-0.69) with
a significant trend (P = 0.001); whereas women with
body mass index > or =25 had no protective effect.
These findings suggest that a diet rich in raw
vegetables and olive oil protects against breast
cancer.
3.2. Olive oil and colon cancer
3.2.1. Experimental data
Colorectal cancer is one of the most common
causes of cancer death in industrialized western
countries. Earlier studies have shown that dietary
fatty acid composition is important in colorectal
carcinogenesis (Reddy, 1988; 1992). The effect of
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fatty acids is different among different species. MUFA
induce lesser bile acids than n-6 PUFA, which is
associated to an increase of cholesterol formation.
However, there are no differences between n-3 and
n-6 PUFA on bile acid synthesis in vitro (Dommels et
al., 2002), whereas in animal studies n-3 PUFA
appear to protect against colorectal carcinogenesis
and n-6 PUFA enhance tumorigenesis.
3.2.2. Epidemiological data
As with studies in breast cancer, all efforts to
achieve a relationship between dietary fatty acids
and colorectal cancer have failed. A combined
analysis of 13 case-control studies indicated that
there was essentially no association of intake of total,
saturated, monounsaturated or polyunsaturated fats
with the risk of colorectal cancer (Howe et al., 1997).
In the last years, scientists have investigated the
effect of long-chain n-3 PUFA (20:5n-3,
eicosapentaenoic acid; 22:6n-3, docosahexaenoic
acid) as the main fat in the diet (consuming large
quantities of fish) in order to prevent not only
colorectal cancer but coronary disease too
(Woutersen et al., 1999; Hong et al., 2000), leaving
aside the olive oil.
3.3. Olive oil and prostate cancer
The early studies suggested a positive
association between prostate carcinogenesis and
saturated fat intake. Many years later, it was
published that death rates from prostate cancer was
lower in areas with high olive oil consumption, such
as Greece and Italy (Rose et al., 1992; Kushi et al.,
1995). However, more recently results have tended
to have null associations (Kolonel, 1996; Kushi et al.,
2002). Kolonel suggests that the discrepancies in
those results may be due to adjust association of
prostate cancer with dietary fat intake.
3.4. Olive oil and other cancers
Studies in Mediterranean countries revealed an
inverse relation between consumption of olive oil and
cancer of the bladder (Gonzalez t al., 1990),
stomach (Buiatti et al., 1989), urinary tract (Bitterman
et al., 1991), lung (Fortes et al., 1995; 2003) and
endometrial (Tzonou et al., 1996b). However, there is
no association in single studies with olive oil and
cancer of pharynx (Franceschi et al., 1991), ovarian
(Tzonou et al., 1993), pancreas (Kalapothak et al.,
1993) and oesophagus (Tzonou et al., 1996a).
4. THE ROLE OF MINOR COMPOUNDS FROM
   OLIVE OIL IN CANCER
Phenolic compounds, commonly referred to as
polyphenols, are present in extra virgin olive oil.
They are a complex mixture of compounds that
include 3,4-dihydroxyphenylethanol (hydroxytyrosol),
4-hydroxyphenylethanol (tyrosol), 4-hydroxyphenylacetic
acid, protocatechuic acid, syringic acid, vanillic acid,
caffeic acid and p-coumaric acid, among others. The
concentration of the phenolic fraction in olive oil
varies depending on the cultivar, climate, and degree
of ripeness of the fruit, being the average
concentration around 500 mg/L in extra virgin olive
oil. These bioactive compounds are ‘‘extra-nutritional’’
constituents that exhibit powerful antioxidant activity.
Of the various phenolic compounds of extra virgin
olive oil, hydroxytyrosol seems to be among the most
important (Brenes t al., 1999; Tuck et al., 2002). It is
present in free form and as a constituent of complex
molecules (e.g. oleuropein) in olives. Its in vitro
antioxidant potency is greater than butylated
hydroxytoluene (Wiseman et al., 1996). In addition,
olive oil phenolics have greater antioxidant potency
than other vegetable oils. Some studies have
demonstrated favourable effects of phenolics on
thrombosis and tumorigenesis and promotion.
4.1. Relationship between ROS and cancer
The importance of antioxidant activity of olive oil
minor compounds lies in the growing evidence that
ROS are involved in the aetiology of fat-related
tumours. ROS production notably increases in
cancerous tissues compared with the normal tissues
(Owen et al., 2000b).
It is considered that 80--90% of all human cancers
are environmentally induced (Jensen and Madsen,
1988) and 30--40% of them by carcinogens present
in our diet (Clemens, 1991). They damage DNA
directly by forming, covalent adducts either with DNA
or indirectly after being activated from inactive
procarcinogens or through ROS they induce.
However, some carcinogens are not genotoxic but
stimulate cell proliferation thus increasing the
probability of spontaneous occurrence of errors
during DNA replication. Finally, some chemical
bonds, including those present in DNA, can
disintegrate spontaneously under physiological
conditions. As mentioned above, one of the
peculiarities of the natural anticancer defence
mechanisms is that they start operating at the stage
preceding the formation of tumour cells. Among ROS
are superoxide anion (·O2-), hydrogen peroxide
(H2O2), hydroxyl radical (OH·), singlet oxygen (1O2),
alkoxyl radical (RO·), and peroxyl radical (ROO·),
with hydroxyl radical being the most active in
damaging DNA. Oxidative damage may include
single- and double-strand breaks, abasic sites, and a
variety of alterations in every constituent of DNA. For
example, oxidative damage to cytosine alone results
in at least 40 modified derivatives (Polverelli and
Teoule, 1974).
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ROS are also formed because of normal cellular
respiration in mitochondria, by neutrophils and
eosinophils in their defence against microorganisms
and during metabolism of steroids and arachidonic
acid. ROS produced by neutrophils probably
participate in the carcinogenic effects of chronic
inflammatory reactions.
4.2. ROS scavenger activity of olive oil
     phenolics
Phenolic compounds from extra virgin olive oil
may directly scavenge some radical species by
acting as chain-breaking antioxidants and suppress
lipid peroxidation by recycling other antioxidants,
such as a-tocopherol, by donating a hydrogen atom
to the tocopherol molecule. a-Tocopherol also may
contribute to the antioxidant effects of olive oil. It is
commonly known that compounds, which share an
orthodiphenolic structure, possess antioxidant
activity and there are a number of the phenolics in
olive oil, which possess this structure, namely
hydroxytyrosol. ROS injuries result in a number of
harmful effects: disturbed cell metabolism,
morphological and ultrastructural changes, attack on
the regulation pathways and, alterations in the
differentiation, proliferation and apoptosis. The
powerful antioxidant activity of phenolics suggests a
protective role for (extra virgin) olive oil in a chronic
disease, such as cancer.
The antioxidant activity of olive oil phenolics has
been widely studied by assessing the bleaching of
the stable 1,1-diphenyl-2-picrylhydrazyl radical
(DPPH) in membranes. The model system consists
of dimyristoylphosphatidylcholine/linoleic acid
unilamellar vesicles and a water azo compound as a
free radical generator. The mean scavenging
concentration (SC50) value of hydroxytyrosol and
oleuropein has been described to be 20.51 and
25.22 mM, respectively (Saija et al., 1998). It appears
that these differences were because hydroxytyrosol
can serve as scavenger of aqueous peroxyl radicals
near the membrane surface, while oleuropein acts
also as a scavenger of chain-propagating lipid
peroxyl radicals within membranes (Tuck and
Hayball, 2002). Gordon et al. (2001) found SC50
values of 26 mM for hydroxytyrosol acetate and 12 mM
for oleuropein aglycone, both phenolic compounds
contained in olive oil (Brenes et al., 1999).
Briante et al. (2001) discovered that the capacity
of oleuropein aglycone, hydroxytyrosol, elenolic acid
with closed ring and elenolic acid with open ring to
inhibit the fatty acid peroxidation rate is related to the
degree of unsaturation of fatty acids. The authors
confirmed that oleuropein and hydroxytyrosol
possess greater antioxidant capacity than elenolic
acid in either form.
Owen et al. (2000a) showed that phenolic
compounds present in (extra virgin) olive oil are potent
inhibitors of free radical generation by the faecal matrix,
suggesting a major role of phenolics is preventing
colorectal cancer. The most potent compound
inhibiting ROS action is (+)-1-acetoxypinoresinol
(0.91 mM) follows by hydroxytyrosol (1.34 mM),
secoiridoid-1 (1.62 mM), p-hydroxybenzoic acid
(1.69 mM) and other phenolic compounds from
(extra virgin) olive oil. Almost all of these compounds
have an IC50, similar to SC50, in a range of 0.9-3.2,
and Trolox had the lowest activity (12.24 mM) (Owen
et al., 2003).
Recent observations have revealed that phorbol
ester (PMA)-stimulated macrophages from animals
fed with (extra virgin) olive oil release less superoxide
than cells from animals fed with fish oil (Moreno et
al., 2001). Both diets decreased eicosanoid
production compared with a corn oil diet.
Furthermore, olive oil and fish oil diets increased
nitric oxide production. Olive oil reduced arachidonic
acid mobilization and the subsequent metabolism of
eicosanoids, but only olive oil increased the nitric
oxide (·NO)/ROS ratio. Tyrosol decreased ROS
production in a concentration-dependent manner
after PMA-stimulation (Moreno et al., 2003).
However, b-sitosterol inhibited ROS (O2- and H2O2)
production when b-sitosterol is incubated for several
hours before PMA-stimulation. These effects were
not observed with squalene. The above-mentioned
treatments did not cause cytotoxicity. These data
hed some light on the mechanism involved in the
beneficial effects of a diet rich in (extra virgin) olive
oil.
4.3. Potential anticancer activity of olive oil
     phenolic compounds
Epidemiological studies suggest that (extra virgin)
olive oil may offer protection for some types of
cancer. Olive oil phenolic compounds reduce ROS
generated both during metabolism of fatty acids
(Mataix et al., 1993; Owen et al., 2000a) and cancer
cells (Owen et al., 2000b), or by the action of
exogenous agents like UV-light and ionizing radiation
(Budiyanto et al., 2000; Ichihashi et al., 2000; Awad
et al., 2003a).
UV-light generates DNA damage products
uch as 8-hydroxy-deoxyguanosine (8-OHdG),
cyclobutane pyrimidine dimmers (CPD) and (6-4)
photoproducts. Studies in animals reveal that
post-treatment with extra virgin olive oil painted
immediately after UV irradiation delay the onset and
reduce the number of skin cancer, but pre-treatment
with extra virgin olive oil and pre/post-treatment with
refined olive oil (no phenolics) neither retard nor
reduce skin cancer formation in UV-irradiated
animals (Budiyanto et al., 2000; Ichihashi et al.,
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2000). These interesting findings indicate that minor
compounds from olive oil have anticancer effects
when tissues are damaged. The beneficial effect of
extra virgin olive oil seems to be related with a
decrease of 8-OHdG formation, with no effect on the
levels of CPD and (6-4) photoproducts. A delay in the
formation and yield of UV-induced skin cancer has
been also described for animals treated with vitamin
E acetate (Berton et al., 1998).
Hydroxytyrosol has been shown to be effective
versus the human promyelocitic line HL60, but not on
colorectal carcinoma cell lines Caco-2 and HT-29
(Ragione et al., 2000). Hydroxytyrosol, at a concentration
of 50-100 mM (comparable with its content in extra virgin
olive oil) caused a complete arrest of HL60 and
induced apoptosis (Figure 1). There was an early
release of cytochrome c from mitochondria, which
precedes the activation of caspases 8 and 3.
The human gingival malignant cell line HSG1
was sensitive to phenolics (Babich and Visioli,
2003). The sequence of increasing cytotoxicity was
oleuropein aglycone>oleuropein glycoside, caffeic
acid>o-coumaric acid>cinnamic acid>tyrosol,
syringic acid, protocatechuic acid, vanillic acid. This
effect was noted only at phenolic concentrations
far exceeding those attainable after habitual
consumption, thus indicating that consumption of
phenol-rich olive oil is safe.
4.4. Potential anticancer activity of olive oil
     sterols
Phytosterols are considered anticancer dietary
components (Moreno, 2003). Studies in human
breast cancer cells have showed that b-sitosterol
inhibits tumour cell invasion and cell growth by 70%
compared with controls and induces cell cycle arrest
at the G2/M phase (Awad et al., 2001). The
mechanistic regulation of growth was through MAPK
pathway (Awad et al., 2003a). Moreover, b-sitosterol
induces apoptosis by the activation of caspases 8, 9
and 3 (Awad et al., 2003b). b-Sitosterol may offer
protection from breast cancer metastasis by
inhibiting cell invasion of the basement membrane
(laminin and collagen IV), which may be mediated by
its ability to limit the adhesiveness of the tumour
cells.
4.5. Potential anticancer activity of olive oil
     tocopherols
Gysin et al. (2002) investigated the effects of the
a-, b-, and g-tocopherol on the growth of human
prostate and colon cancer cells. They showed that
although all of them inhibit the cell growth, was
a-tocopherol which strongest induced a significant
growth inhibition (86%) in androgen-independent
prostate cancer cell line DU-145 (50% by a-tocopherol
and 41% by b-tocopherol). Androgen-dependent
prostate cancer cell line LNCaP was sensitive to
tocopherols; cells grew only 26% relative to controls
vs. 52% growth observed from a-tocopherol-treated
cells. The ability to proliferate of human colon
adenocarcinoma (Caco-2) cells was reduced when
treated with g-tocopherol (64%) and a-tocopherol
(50%). Thus, inhibition f cell proliferation in DU-145,
LNCaP, and Caco-2 cells was consistently inhibited
more significantly by g- than by a- or b-tocopherol.
Human osteosarcoma cell proliferation, on the other
hand, was only weakly inhibited by g-tocopherol,
whereas proliferation of a-tocopherol-treated cells
was not distinguishable from that of controls. These
observations were basically due to a decrease in the
levels of cyclin D1 and E, and an increase in the
levels of three cdk inhibitors (CKI): p21, p27 and p16
(Figure 2).
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Apoptotic effects of hydroxytyrosol.
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Tocopherols diminish protein levels for proteins important in
G1-S transition, DNA synthesis and cell proliferation
(adapted from Gysin et al., 2002).
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However, our body retains more a-tocopherol than
g-tocopherol (Burton et al., 1998; Brigelius-Flohe et
al., 1999). The biological antioxidant and
non-antioxidant activities of a-tocopherol are well
known (Azzi et al., 2003; Villacorta et al., 2003), and
g-tocopherol has benefits by reducing the rate of
sister chromatid exchange in humans (Elmadfa et al.,
1999). Taken together, we can draw in mind a cellular
mechanism supporting the concept emerging from
epidemiological studies that a greater magnitude of
risk reduction for prostate and colon cancer may
occur if both total vitamin E consumption and the
amount of g-tocopherol in the diet are increased.
4.6. Potential anticancer activity of olive oil
     squalene
Squalene is an isoprenoid compound comprised of
six isoprene units. The antioxidant property of squalene
may be related to these isoprene units. Olive oil
contains 0.2-0.7% of squalene. The intakes of squalene
in Mediterranean countries reach 200-400 mg/day
(Newmark, 1999; Smith, 2000), which could raise the
plasma level of squalene to approximately 10 mM.
Squalene may have chemopreventive activity
against colon carcinogenesis (Rao et al., 1998;
Newmark, 1999). Its mechanism of action lies on the
strong inhibition of 3-hydroxy-3-methylglutaryl
coenzyme A (HMG-CoA) reductase activity, which
reduces the availability of farnesyl pyrophosphate for
the phenylation of the ras oncogene.
Experiments in animals show that consumption of
squalene significantly inhibits the formation of colonic
crypt foci (ACF) by 46% (Rao et al., 1998) and lung
hyperplasia by 70% (Smith et al., 1998). Normal human
bone marrow (BM) derived colony-forming unit (CFU)
growth can be increased by squalene in a
dose-dependent manner (Das et al., 2003). Squalene
(12.5--25 mM) treatment significantly protected the
CFUs from cisplatin-induced toxicity; the protective
effect was equivalent to reduced glutathione (GSH).
No evidence in humans has been discovered in vivo
yet. There is an urgent need for the clinical
development of safe and non-toxic cytoprotective
agents for the adequate management of cancer
chemotherapy. A phase I trial demonstrated that oral
squalene is safe and tolerable (Chan et al., 1996). In
the study, adult males were given 860 mg of
squalene daily for 20 weeks.
4.7. Potential anticancer activity of olive oil
     carotenoids
The major carotenoid compound in (extra virgin)
olive oil is b-carotene, but also contains a-carotene,
lycopene, b-cryptoxanthin and lutein-zeaxanthin.
More than a hundred of epidemiological studies have
shown that people who consume more b-carotene
(provitamin A) and have higher b-carotene levels in
their blood have lower risk of cancer and particularly
lung cancer (Nowak, 1994). Diet supplementation
with b-carotene has been undertaken in two large
clinical studies, but unexpectedly and tragically this
supplementation resulted in the increased incidence
of lung cancer in those smoking cigarettes (Omenn
et al., 1996). We still do not know the final
explanation.
A diet rich in lutein + zeaxanthin and long-chain
PUFA may help to prevent human colon cancer
(Nkondjock and Ghadirian, 2004). Lutein concentration
in plasma is inversely associated with human cancer
death (Mayne et al., 2004). Additionally, lycopene
inhibits proliferation of tumoral cells (Olmedilla et a .,
2001), and is a potential preventative in human
prostate cancer (Klein and Thompson, 2004) and
reduces risk of prostate, lung and digestive cancers
(Tapiero et al., 2004).
ACKNOWLEDGMENTS
The authors would like to acknowledge to the
Ministry of Education and Science (ECI) of the
Spanish Government for supporting this manuscript
(grant AGL2001-0584). Beatriz Bermúdez and
Sergio López are supported by I3P and FPU
fellowships, whereas Yolanda M. Pacheco has an I3P
Post-Doctoral contract from ECI.
REFERENCES
Awad, A.B., Williams, H., Fink, C.S. (2001). Phytosterols
reduce in vitro metastatic ability of MDA-MB-231
human breast cancer cells. Nutr. Cancer, 40, 157-164.
Awad, A.B., Williams, H., Fink, C.S. (2003a). Effect of
phytosterols on cholesterol metabolism and MAP
kinase in MDA-MB-231 human breast cancer cells. J.
Nutr. Biochem., 14, 111-119.
Awad, A.B., Roy, R., Fink, C.S. (2003b). Beta-sitosterol, a
plant sterol, induces apoptosis and activates key
caspases in MDA-MB-231 human breast cancer cells.
Oncol. Rep., 10, 497-500.
Azzi, A., Gysin, R., Kempna, P., Ricciarelli, R., Villacorta,
L., Visarius, T., Zingg, J.M. (2003). The role of
a-tocopherol in preventing disease: from epidemiology
to molecular events. Mol. Aspects Med., 24, 325-336.
Babich, H., Visioli, F. (2003). In vitro cytotoxicity to human
cells in culture of some phenolics from olive oil.
Farmaco, 58, 403-407.
Berton, T.R., Conti, C.J., Mitchell, D.L., Aldaz, M., Lubet,
R., Fischer, S.M. (1998). The effect of vitamin E acetate
on ultraviolet-induced mouse skin carcinogenesis.
Carcinogenesis, 23, 175-184.
Bitterman, W.A., Farhadian, H., Abu Samra, C., Lerner, D.,
Amoun, H., Krapf, D., Makov, U.E. (1991).
Environmental and nutritional factors significantly
associated with cancer of the urinary tract among
different ethnic groups. Urol. Clin. North Am., 18,
501-508.
Brenes, M., Garcia, A., Garcia, P., Rios, J.J., Garrido, A.
(1999). Phenolic compounds in spanish olive oil. J.
Agric. Food Chem., 47, 3535-3540.
Vol. 55. Fasc. 1 (2004) 39
Briante, R., La Cara, F., Tonziello, M.P., Febbraio, F., Nucci, R.
(2001). Antioxidant activity of the main bioactive derivates
from oleuropein hydrolisis by hyperthermophilic
beta-glycosidase. J. Agric. Food Chem., 49,
3198-3203.
Brigelius-Flohe, R., Traber, M.G. (1999). Vitamin E: function
and metabolism. FASEB J. , 13 1145-1155.
Budiyanto, A., Ahmed, N.U., Wu, A., Bito, T., Nikaido, O.,
Osawa, T., Ueda, M., Ichihashi, M. (2000). Protective
effect of topically applied olive oil against
photocarcinogenesis following UVB exposure of mice.
Carcinogenesis, 21, 2085-2090.
Buiati, E., Palli, D., Decarli, A., Amadori, D., Avellini, C.,
Bianchi, S., et al. (1989). A case-control study of
gastric cancer in Italy. Int. J. Cancer, 44, 611-616.
Burton, G.W., Traber, M.G., Acuff, R.V., Walters, D.N.,
Kayden, H., Hughes, L., Ingold, K.U. (1998). Human
plasma and tissue alpha-tocopherol concentrations in
response to supplementation with deuterated natural
and synthetic vitamin E. Am. J. Clin. Nutr., 67, 669-684.
Chan. P., Tomlinson, B., Lee, C.B., Lee, Y.S. (1996).
Effectiveness and safety of low-dose pravastatin and
squalene, alone and in combination, in elderly patients
with hypercholesterolemia. J. Clin. Pharmacol., 36,
422-427.
Clemens, M.R. (1991). Free radicals in chemical
carcinogenesis. Klin. Wochenschr., 69, 1123-1134.
Cohen, L.A. (1987). Fat and endocrine-responsive cancer
in animals. Prev. Med., 16, 468-474.
Cohen, L.A., Choi, K., Weisburger, J.H., Rose, D.P.
(1986b). Effect of varying proportions of dietary fat on
the development of N-nitrosomethylurea.induced rat
mammary tumours. Anticancer Res., 6, 215-218.
Cohen, L.A., Thompson, D.O., Maeura, Y., Choi, K., Blank,
M.E., Rose, D.P. (1986a). Dietary fat and mammary
cancer. I. Promoting effects of different dietary fats on
N-nitrosomethylurea rat mammary tumorigenesis. J.
Natl. Cancer Inst., 77, 33-42.
Das, B., Yeger, H., Baruchel, H., Freedman, M.H., Koren,
G., Baruchel, S. (2003). In vitro cytoprotective activity
of squalene on a bone marrow versus neuroblastoma
model of cisplatin-induced toxicity. implications in
cancer chemotherapy. Eur. J. Cancer, 39, 2556-2565.
Dommels, Y.E., Alink, G.M., Linssen, J.P., Van Ommen, B.
(2002). Effects of n-6 and n-3 polyunsaturated fatty
acids on gap junctional intercellular communication
during spontaneous differentiation of the human colon
adenocarcinoma cell line Caco-2. Nutr. Cancer, 42,
125-130.
Elmadfa, I., Park, E. (1999). Impact of diets with corn oil or
olive/sunflower oils on DNA damage in healthy young
men. Eur. J. Nutr., 38, 286-292.
Fortes, C., Forastiere, F., Anatra, F., Schmid, G. (1995).
Consumption of olive oil and specific groups in relation
to breast cancer risk in Greece. J. Natl. Cancer Inst.,
87, 1020-1021.
Fortes, C., Forastiere, F., Farchi, S., Mallone, S.,
Trequattrinni, T., Anatra, F., Schmid, G., Perucci, C.A.
(2003). The protective effect of the Mediterranean diet
on lung cancer. Nutr. Cancer, 46, 30-37.
Franceschi, S., Bidoli, E., Baron, A.E., Barra, S., Talamini,
R., Serraino, D., La Vecchia, C. (1991). Nutrition and
cancer of the oral cavity and pharynx in north-east Italy.
Int. J. Cancer, 47, 20-25.
Gaard, M., Tretli, S., Loken, E.B. (1995). Dietary fat and the
risk of breast cancer: a prospective study of 25,892
Norwegian women. Int. J. Cancer, 63, 13-17.
Gonzalez, C.A., Torrent, M., Agudo, A. (1990). Dietary
habits in Spain: an approximation. Tumori, 76, 311-314.
Gordon, M.H., Paiva-Martins, F., Almeida, M. (2001).
Antioxidant activity of hydroxytyrosol acetate
compared with that of other olive oil polyphenols. J.
Agric. Food Chem., 49, 2480-2485.
Gysin, R., Azzi, A., Visarius, T. (2002). a-Tocopherol
inhibits human cancer cell cycle progresion and cell
proliferation by down-regulation of cyclins. FASEB J. ,
16, 1952-1954.
Holmes, M.D., Hunter, D.J., Colditz, G.A., Stampfer, M.J.,
Hankinson, S.E., Speizer, F.E., Rosner, B., Willett, W.C.
(1999). Association of dietary intake of fat and fatty
acids with risk of breast cancer. JAMA , 281, 914-920.
Hong, M.Y., Lupton, J.R., Morris, J.S., Wang, N., Carrol,
R.J., Davidson, L.A., Elder, R.H., Chapkin, R.S. (2000).
Dietary fish oil reduces O6-methylguanine DNA adduct
levels in rat colon in part by increasing apoptosis
during tumour initiation. Cancer Epidemiol. Biomarkers
Prev., 9, 819-826.
Howe, G.R., Aronson, K.J., Benito, E., Castellano, R.,
Cornee, J., Duffy, S., et al. (1997). The relationship
between dietary fat intake and risk of colorectal cancer:
Evidence from the combined analysis of 13
case-control studies. Cancer Causes Control, 8,
215-228.
Hunter, D.J., Spiegelman, D., Adami, H.O., Beeson, L., Van
den Brandt, P.A., Folsom, A.R., et al. (1996). Cohort
studies of fat intake and the risk of breast cancer -- a
pooled analysis. N. Engl. J. Med., 334, 356-361.
Ichihashi, M., Ahmed, N.U., Budiyanto, A., Wu, A., Bito, T.,
Ueda, M., Osawa, T. (2000). Preventive effect of
antioxidant on ultraviolet-induced skin cancer in mice.
J. Dermatol. Sci., 23, S45-S50.
Ip, C., Carter, C.A., Ip, M.M. (1985). Requirement of
essential fatty acid for tumorigenesis in the rat. Cancer
Res., 45, 1997-2001.
Jakobisiak, M., Lasek, W., Golab, J. (2003). Natural
mechanisms protecting against cancer. Immunol. Lett.,
90, 103-22.
Jensen, H., Madsen, J.L. (1988). Diet and cancer. Review
of the literature. Acta Med. Scand., 223, 293-304.
Kalapothaki, V., Tzonou, A., Hsieh, CC., Karakatsani, A.,
Trichopoulou, A., Toupadaki, N., Trichopoulos, D.
(1993). Nutrient intake and cancer of the pancreas: a
case-control study in Athens, Greece. Cancer Causes
Control, 4, 383-389.
Klein, E.A., Thompson, I.M. (2004). Update on
chemoprevention of prostate cancer. Cu r. Opin. Urol.,
14, 143-149.
Kolonel, L.N. (1996). Nutrition and prostate cancer. Cancer
Causes Control, 7, 83-94.
Kushi, L.H., Lenart, E.B., Willet, W.C. (1995). Health
implications of Mediterranean diets in light of
contemporary knowledge. 2. Meat, wine, fats and oils.
Am. J. Clin. Nutr., 61, 1416-1427.
Kushi, L., Giovannucci, E. (2002). Dietary fat and cancer.
Am. J. Med., 113, 63S-70S.
Lipworth, L., Bailey, L.R., Trichopoulos, D. (2000). History
of breast-feeding in relation to breast cancer risk: a
review of the epidemiologic literature. J. Natl. Cancer
Inst., 92, 302-312.
Mataix, J. (1993). Recent findings in olive oil research. Eur.
J. Clin. Nutr., 47, 561-569.
Martin-Moreno, J.M., Willet, W.C., Gorgojo, L., Banegas,
J.R., Rodriguez-Artalejo, F., Fernandez-Rodriguez,
J.C., Maisonneuve, P., Boyle, P. (1994). Dietary fat,
olive oil intake and breast cancer risk. Int. J. Cancer,
58, 774-780.
Mayne, S.T., Cartmel, B., Lin, H., Zheng, T., Goodwin, W.J.
Jr. (2004). Low plasma lycopene concentration is
40 Grasas y Aceites
associated with increased mortality in a cohort of
patients with prior oral, pharynx or larynx cancers. J.
Am. Coll. Nutr., 23, 34-42.
Moreno, J.J. (2003). Effect of olive oil minor components on
oxidative stress and arachidonic acid mobilization and
metabolism by macrophages raw 264.7. Free Radic.
Biol. Med., 35, 1073-1081.
Moreno, J.J., Carbonell, T., Sanchez, T., Miret, S., Mitjavila,
M.T. (2001). Olive oil decreases both oxidative stress
and the production of arachidonic acid metabolites by
the prostaglandin G/H synthase pathway in rat
macrophages. J Nutr., 131, 2145-2149.
Newmark, H.L. (1999). Squalene, olive oil, and cancer risk.
Review and hypothesis. Ann. N. Y. Acad. Sci., 889,
193-203.
Nkondjock, A., Ghadirian, P. (2004). Dietary carotenoids
and risk of colon cancer: case-control study. Int. J.
Cancer, 110, 110-116.
Nowak, R. (1994). Cancer prevention. Beta-carotene:
helpful or harmful?. Science, 264, 500-501.
Olmedilla, B., Granado, F., Blanco, I. (2001). Carotenoides
y Salud Humana. Fundación Española de la Nutrición
(FEN).
Omenn, G.S., Goodman, G.E., Thornquist, M.D., Balmes,
J., Cullen, M.R., Glass, A., Keogh, J.P., Meyskens, F.L.,
Valanis, B., Williams, J.H., Barnhart, S., Hammar, S.
(1996). Effects of a combination of beta-carotene and
vitamin A on lung cancer and cardiovascular disease.
N. Engl. J. Med., 334, 1150-1155.
Owen, R.W., Giacosa, A., Hull, W.E., Haubner, R.,
Spiegelhalder, B., Bartsch, H. (2000a). The
antioxidant/anticancer potential of phenolic
compounds isolated from olive oil. Eur J. Cancer, 36,
1235-1247.
Owen, R.W., Spiegelhalder, B., Bartsch, H. (2000b).
Generation of reactive oxygen species by the faecal
matrix. Gut, 46, 225-232.
Owen, R.W., Haubner, R., Hull, W.E., Erben, G.,
Spiegelhalder, B., Bartsch, H., Haber, B. (2003).
Isolation and structure elucidation of the major
individual polyphenols in carob fibre. Food Chem.
Toxicol., 41, 1727-1738.
Polverelli, M., Teoule, R. (1974). Gamma irradiation of
cytosine in an aerated aqueous solution. I.
Identification of radiolysis products of cytosine
resulting from the deamination pathway. Z.
Naturforsch., 29, 12--15.
Potter, J.D. (1996). Nutrition and colorectal cancer. Cancer
Causes Control, 7, 127-146.
Ragione, F.D., Cucciolla, V., Borriello, A., Pietra, V.D.,
Pontoni, G., Racioppi, L., Manna, C., Galleta, P.,
Zappia, V. (2000). Hydroxytyrosol, a natural molecule
occurring in olive oil, induces cytochrome c-dependent
apoptosis. Biochem. Biophys. Res. Commun., 278,
733-739.
Rao, C.V., Newmark, H.L., Reddy, B.S. (1998).
Chemopreventive effect of squalene on colon cancer.
Carcinogenesis, 19, 287-290.
Reddy, B.S. (1988). Overview of diet and colon cancer.
Prog. Clin. Biol. Res., 279, 111-121.
Reddy, B.S. (1992). Dietary fat and colon cancer: animal
model studies. Lipids, 35, 3388-3394.
Rose, D.P., Connolly, J.M. (1992). Dietary fat, fatty acids
and prostate cancer. Lipids, 27, 798-803.
Saija, A., Trombetta, D., Tomaino, A., Lo Cascio, R., Princ.,
P., Uccella, N., Bonina, F., Castelli, F. (1998). In vitro
evaluation of the antioxidant activity and biomembrane
interaction of the plant phenols oleuropein and
hydroxytyrosol. Int. J. Pharmaceut., 166, 123-133.
Sieri, S., Krogh, V., Pala, V., Muti, P., Micheli, A.,
Evangelista, A., Tagliabue, G., Berrino, F. (2004).
Dietary patterns and risk of breast cancer in the
ORDET cohort. Cancer Epidemiol. Biomarkers Prev.,
13, 567-572.
Smith, T.J., Yang, G.Y., Seril, D.N., Liao, J., Kim, S. (1998).
Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-
1-butanone induced lung tumorigenesis by dietary
olive oil and squalene. Carcinogenesis, 19, 703-706.
Smith, T.J. (2000). Squalene: potential chemopreventive
agent. Expert Opin. Investig. Drugs, 9, 1841-1848.
Tapiero, H., Townsend, D.M., Tew, K.D. (2004). The role of
carotenoids in the prevention of human pathologies.
Biomed Pharmacother., 58, 100-110.
Trichopoulou, A., Katsouyanni, K., Stuver, S., Tzala, L.,
Gnardellis, C., Rimm, E., Trichopoulous, D. (1995).
Consumption of olive oil and specific food groups in
relation to breast cancer risk in Greece. J. Natl. Cancer
Inst., 87, 110-116.
Tuck, K.L., Hayball, P.J. (2002). Major phenolic compounds
in olive oil: metabolism and health effects. J. Nutr.
Biochem., 13, 636-644.
Tuck, K.L., Hayball, P.J., Stupans, I. (2002). Structural
characterization of the metabolites of hydroxytyrosol,
the principal phenolic component in olive oil, in rats. J.
Agric. Food Chem., 50, 2404-2409.
Tzonou, A., Hsieh, CC., Polychronopoulou, A., Kaprinis,
G., Toupadaki, N., Trichopoulou, A., Karakatsani, A.,
Trichopoulos, D. (1993). Diet and ovarian cancer: a
case-control study in Greece. Int. J. Cancer, 55,
411-414.
Tzonou, A., Lipworth, L., Garidou, A., Signorello, L.B.,
Lagiou, P., Hsieh, C., Trichopoulos, D. (1996a). Diet and
risk of esophageal cancer by histologic type in a
low-risk population. I t. J. Cancer, 68, 300-304.
Tzonou, A. Lipworth, L., Kalandidi, A., Trichopoulou, A.,
Gamatsi, I., Hsieh, C.C., Notara, V., Trichopoulou, D.
(1996b). Dietary factors and the risk of endometrial
cancer: a case-control study in Greece. Br. J. Cancer,
73, 1284-1290.
Villacorta, L., Graca-Souza, A.V., Ricciarelli, R., Zingg,
J.M., Azzi, A. (2003). Alpha-tocopherol induces
expression of connective tissue growth factor and
antagonizes tumor necrosis factor-alpha-mediated
downregulation in human smooth muscle cells. Circ.
Res., 92, 104-110.
Weisburger, J.H. (1997). Dietary fat and risk of chronic
disease: Mechanistic insights from experimental
studies. Am. Diet Assoc., 97, S16-S23.
Willet, W.C. (1997). Specific fatty acids and risks of breast
and prostate cancer: dietary intake. Am. J. Clin. Nutr.,
66, 1557S-1563S.
Willet, W.C. (2001). Diet and breast cancer. J. Intern. Med.,
249, 395-411.
Wiseman, A., Mathot, J.N., de Fouw, N.J., Tijburg, L.B.M.
(1996). Dietary non-tocopherol antioxidants present in
extra virgin olive oil increase the resistance of
low-density lipoproteins to oxidation in rabbits.
Atherosclerosis, 120, 15--23.
Woutersen, R.A., Appel, M.J., Van Garderen-Hoetmer, A.,
Wijnands, M.V. (1999). Dietary fat and carcinogenesis.
Mutat. Res., 443, 111-127.
Yu, S.Z., Lu, R.F., Xu, D.D., Howe, G.R. (1990). A
case-control study of dietary and nondietary risk
factors for breast cancer in Shanghai. C ncer Res., 50,
5017-5021.
Yuan, J.M, Wang, Q.S., Ross, R.K., Henderson, B.E., Yu,
M.C. (1995). Diet and breast cancer in Shanghai and
Tianjin, China. Br. J. Cancer, 71, 1353-1358.
Vol. 55. Fasc. 1 (2004) 41
